SCHEMBL4848073

SCHEMBL4848073

CN(C)CCOc1ccc(-c2ccccc2Br)cc1C=CC(=O)c1ccccc1CN(C)C

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 2/20 0.41
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PTPN1 P18031 3/20 0.41
HRH1 P35367 1/20 0.40
MAOB P27338 1/20 0.39
AR P10275 2/20 0.39
BCHE P06276 2/20 0.38
ACHE P22303 2/20 0.38
PTPN11 Q06124 1/20 0.37
UTS2R Q9UKP6 1/20 0.37
SLC6A9 P48067 1/20 0.36
MCHR1 Q99705 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4851092 0.91 ALDH1A1 (0.42) HTR7ALDH1A1KDM4ESMN1; SMN2PTPN1
SCHEMBL4847450 0.91 SLC6A9 (0.43) HTR7ALDH1A1KDM4ESMN1; SMN2PTPN1
SCHEMBL4853598 0.91 MAOB (0.41) HTR7ALDH1A1KDM4ESMN1; SMN2PTPN1
SCHEMBL4857272 0.90 AR (0.41) HTR7ALDH1A1KDM4ESMN1; SMN2PTPN1
SCHEMBL4848106 0.90 SLC6A9 (0.44) HTR7ALDH1A1KDM4ESMN1; SMN2HRH1
SCHEMBL4848069 0.90 AR (0.41) HTR7ALDH1A1KDM4ESMN1; SMN2PTPN1
SCHEMBL6394376 0.90 HTR7 (0.46) HTR7ALDH1A1KDM4ESMN1; SMN2PTPN1
SCHEMBL4847477 0.89 ALDH1A1 (0.40) HTR7ALDH1A1KDM4ESMN1; SMN2PTPN1
SCHEMBL4849898 0.88 ALDH1A1 (0.39) HTR7ALDH1A1KDM4ESMN1; SMN2PTPN1
SCHEMBL4847804 0.87 MAOB (0.42) ALDH1A1KDM4ESMN1; SMN2HRH1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed